Audit

Tidepool Achieves SOC 2 Type II Compliance

Retrieved on: 
Friday, April 5, 2024
Software, Health, Diabetes, Data Management, Health Technology, Technology, Other Technology, Security, Single sign-on, SOC, AICPA, CSA, Attention, Risk management, PHI, GDPR, CCPA, NIST, HIPAA, American Institute, SAAS, PCI, SSO, EHR, SOC 2, ISO, Data management, Certified Public Accountant, Audit

Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce the achievement of SOC 2 Type II compliance in accordance with American Institute of Certified Public Accountants (AICPA) standards for SOC for Service Organizations also known as SSAE 18.

Key Points: 
  • Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce the achievement of SOC 2 Type II compliance in accordance with American Institute of Certified Public Accountants (AICPA) standards for SOC for Service Organizations also known as SSAE 18.
  • Achieving this standard with an unqualified opinion serves as third-party industry validation that Tidepool provides enterprise-level security for customers’ data secured in the Tidepool Data Platform.
  • “With this attestation, we are confirming our ongoing commitment to the compliance standards reflected in achieving and maintaining SOC 2 Type II compliance,” says Ben Derr, Lead Security Engineer at Tidepool.
  • An unqualified opinion on an SOC 2 Type II audit report demonstrates to Tidepool’s current and future customers that they manage their data with the highest standard of security and compliance.

Kinetik Announces Changes to Its Board of Directors

Retrieved on: 
Thursday, April 4, 2024
Energy, Other Energy, Oil, Gas, Health, Partner, Natural gas, Audit, Growth, Enterprise Products, KNTK, Retirement, Safety, Chemical engineering, Engineering, Management

Kinetik Holdings Inc. (NYSE: KNTK) (“Kinetik” or the “Company”) announced the appointment of William (“Bill”) Ordemann to the Kinetik Board of Directors, effective April 3, 2024.

Key Points: 
  • Kinetik Holdings Inc. (NYSE: KNTK) (“Kinetik” or the “Company”) announced the appointment of William (“Bill”) Ordemann to the Kinetik Board of Directors, effective April 3, 2024.
  • Additionally, coinciding with Apache’s full exit from its shareholding position in Kinetik, Ben Rodgers resigned from the Board of Directors effective April 3, 2024.
  • Mr. Ordemann will replace Mr. Rodgers, and the Board will continue to consist of eleven independent directors.
  • Ben Rodgers went on to say, “The relationship between Apache and Kinetik will always be unique and special, and I enjoyed the opportunity to serve on the Board of Directors.

Charles River Associates (CRA) Strengthens its Energy Practice

Retrieved on: 
Thursday, April 4, 2024
Consulting, Professional Services, Finance, Government, Risk management, American Electric, Risk, CRA, CRA International, Policy, University, CRAI, NERC, Energy, JD, Audit

Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services , today announced that Andrew Dressel has joined the firm as a vice president in the company’s Energy Practice.

Key Points: 
  • Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services , today announced that Andrew Dressel has joined the firm as a vice president in the company’s Energy Practice.
  • “Andrew is an experienced power industry attorney and consulting professional, and we are excited to have him on our team,” said CRA President and Chief Executive Officer Paul Maleh .
  • He was previously the director of regulatory services and legal counsel at a specialty consultancy.
  • Mr. Dressel has a BS in Resource Conservation from the University of Montana and a JD from Vermont Law School.

The AI-Based Smart Contract Audit Service "Bunzz Audit" Has Officially Launched

Retrieved on: 
Tuesday, April 2, 2024
Technology, Security, Professional Services, Blockchain, Software, Cryptocurrency, Data Management, Web3, Artificial Intelligence, Risk, Logic, Human, Multimedia, ROI, Knowledge, Database, Research, Audit, Communication, AI

As a measure, "smart contract audits (Audit)" are conducted, but users of existing major audit firms face the following challenges:

Key Points: 
  • As a measure, "smart contract audits (Audit)" are conducted, but users of existing major audit firms face the following challenges:
    Emphasis is placed on the "seal of approval" from major audit firms, making the original goal of "improving security" a mere formality.
  • Engaging an audit firm can delay product launches or token listings due to the time taken for audits.
  • As an approach to solve these issues, Bunzz, the smart contract development infrastructure, has researched and developed an AI-based audit service, "Bunzz Audit."
  • In the open beta version in January this year, we received a lot of positive feedback, and we have now officially launched "Bunzz Audit" as a formal version.

CC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Chemours Company Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Friday, March 29, 2024
Class Action Lawsuit, Professional Services, Legal, Annual report, Ethics, CC, CFO, Air conditioning, Electronics, Refrigeration, Controller, Transport, Senior, Complaint, Adjustment, Plastic, Collection, Court, Audit committee, Person, Audit

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) and certain of its officers.

Key Points: 
  • Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) and certain of its officers.
  • Prior to and during the Class Period, according to the Complaint, Chemours set and publicized certain criteria for executive compensation.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

Biome Analytics Introduces AI-Powered Documentation Audit Product to Enhance Cardiovascular Data Accuracy and Revenue Optimization

Retrieved on: 
Thursday, March 28, 2024
Cardiology, Software, General Health, Health, Artificial Intelligence, Data Management, Health Technology, Technology, Diabetes, Organization, Documentation, Artificial intelligence, Audit

Biome Analytics, the leader in cardiovascular performance improvement solutions, is pleased to announce the launch of its latest innovation, the Biome Risk Audit.

Key Points: 
  • Biome Analytics, the leader in cardiovascular performance improvement solutions, is pleased to announce the launch of its latest innovation, the Biome Risk Audit.
  • Developed to address challenges in risk reporting and documentation accuracy in cardiovascular care, this artificial intelligence (AI) enabled tool integrates traditionally siloed quality data and billing information to improve publicly reported outcomes and maximize revenue opportunities.
  • The Biome Risk Audit solves longstanding challenges with risk reporting and documentation accuracy.
  • "Our Bi-Directional Risk Audit Engine provides cardiovascular teams with practical tools to enhance documentation accuracy and revenue, saving healthcare teams hundreds of hours."

Lost Money in the Chemours Company? Gibbs Law Group Investigates Potential Securities Law Violations

Retrieved on: 
Friday, March 29, 2024
Class Action Lawsuit, Professional Services, Legal, Audit, CFO, News, Controller, Eric Gibbs, Audit committee, Cryptocurrency

Gibbs Law Group announces that a class action lawsuit has been filed against the Chemours Company (“Chemours”) (NYSE: CC), on behalf of investors who purchased or acquired shares between February 10, 2023, and February 28, 2024.

Key Points: 
  • Gibbs Law Group announces that a class action lawsuit has been filed against the Chemours Company (“Chemours”) (NYSE: CC), on behalf of investors who purchased or acquired shares between February 10, 2023, and February 28, 2024.
  • The lawsuit alleges that Chemours “had deficient accounting practices and procedures, including internal control over financial reporting,” among other allegations.
  • Our investigation concerns whether Chemours has violated federal securities laws by providing false or misleading statements to investors.
  • What is the Chemours Company Securities Lawsuit Investigation About?

BLUE LOSS ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation – BLUE

Retrieved on: 
Wednesday, March 27, 2024
Class Action Lawsuit, Professional Services, Legal, Titan, News, EY, Bank statement, Advertising, Bluebird, Audit committee, Audit

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=23717 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Chemours Announces Completion of Planned Procedures by the Audit Committee with Respect to Internal Review

Retrieved on: 
Wednesday, March 27, 2024
Chemicals, Plastics, Manufacturing, Audit, CC, Acceleration, Chemours, Audit committee, Bank statement, Compensation, Collection, Annual general meeting

The Audit Committee’s internal review determined that there was a lack of transparency with the Company's Board of Directors by three former members of senior management.

Key Points: 
  • The Audit Committee’s internal review determined that there was a lack of transparency with the Company's Board of Directors by three former members of senior management.
  • The Compensation and Leadership Development Committee of the Company’s Board of Directors took the results of the Audit Committee’s internal review into account and exercised full negative discretion in making cash and equity compensation determinations with regard to these former members of senior management.
  • Additional details regarding these Compensation and Leadership Development Committee actions will be included in the Company’s Compensation Discussion and Analysis in its proxy statement for its 2024 Annual Meeting, when filed.
  • The Company is in the process of designing and implementing enhancements to its internal control over financial reporting.

Castle Biosciences Announces Updates to its Board of Directors

Retrieved on: 
Wednesday, March 27, 2024
Other Health, Pharmaceutical, Oncology, Mental Health, General Health, Medical Devices, Hospitals, Neurology, Genetics, Science, Biotechnology, Other Science, Health, Research, Medical Supplies, Audit, Face, California State University, Health equity, Bias, COVID-19, Roche, Acquisition, University, Indiana State University, MBA, Quality, Sagamore, Francisco Partners, Annual general meeting, Management

The Company further announced that Mara G. Aspinall will not stand for re-election to its board, and her current term will expire at the 2024 Annual Meeting.

Key Points: 
  • The Company further announced that Mara G. Aspinall will not stand for re-election to its board, and her current term will expire at the 2024 Annual Meeting.
  • “Mara has been a great partner and contributor,” said Derek Maetzold, director, president and chief executive officer of Castle Biosciences.
  • “Rod’s broad range of leadership experience in the diagnostic industry will be a significant benefit to our board.
  • With Cotton’s addition, the Company’s board will be comprised of nine directors, five of whom have been appointed in the past four years.